280 related articles for article (PubMed ID: 36713509)
1. Development and validation of a GRGPI model for predicting the prognostic and treatment outcomes in head and neck squamous cell carcinoma.
Han F; Wang HZ; Chang MJ; Hu YT; Liang LZ; Li S; Liu F; He PF; Yang XT; Li F
Front Oncol; 2022; 12():972215. PubMed ID: 36713509
[TBL] [Abstract][Full Text] [Related]
2. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
Yang F; Zhou LQ; Yang HW; Wang YJ
Front Genet; 2022; 13():927614. PubMed ID: 36092911
[No Abstract] [Full Text] [Related]
3. Inflammatory response-related genes predict prognosis in patients with HNSCC.
Jing SL; Afshari K; Guo ZC
Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
[TBL] [Abstract][Full Text] [Related]
4. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
5. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study.
Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB
Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709
[TBL] [Abstract][Full Text] [Related]
7. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma.
Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J
BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442
[TBL] [Abstract][Full Text] [Related]
8. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
Front Genet; 2022; 13():1085700. PubMed ID: 36579330
[No Abstract] [Full Text] [Related]
9. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
Liu J; Lu J; Li W
BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis-related LncRNAs are potential prognostic and immune response markers for patients with HNSCC via the integration of bioinformatics analysis and experimental validation.
Zhou L; Cheng Q; Hu Y; Tan H; Li X; Wu S; Zhou T; Zhou J
Front Oncol; 2022; 12():1030802. PubMed ID: 36620545
[TBL] [Abstract][Full Text] [Related]
11. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance analysis of glycolysis-related genes in HNSCC.
Yuan Q; Mao M; Xia X; Yang W
J Gene Med; 2024 Feb; 26(2):e3670. PubMed ID: 38337164
[TBL] [Abstract][Full Text] [Related]
13. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
14. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
[TBL] [Abstract][Full Text] [Related]
15. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
16. A composite score based on immune-related gene prognostic index and m
Yang Y; Cai Z; Huang K; Li M; Wang X; Lin Y; Chen S; Yang Z; Lin Z
Front Genet; 2023; 14():1061569. PubMed ID: 36845378
[No Abstract] [Full Text] [Related]
17. Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.
Li SR; Man QW; Liu B
Front Oncol; 2022; 12():943945. PubMed ID: 36452497
[TBL] [Abstract][Full Text] [Related]
18. Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma.
Lu Y; Jia Z
Int J Gen Med; 2022; 15():4793-4805. PubMed ID: 35592543
[TBL] [Abstract][Full Text] [Related]
19. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
[TBL] [Abstract][Full Text] [Related]
20. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
Front Oncol; 2022; 12():857994. PubMed ID: 35619896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
